Sun Pharma share price falls 3% on 11 observations from USFDA for Dadra unit
Sun Pharma | April 17, 2017
Sun Pharmaceutical Industries share price fell 3 percent intraday Monday. Investors turned cautious as sources told CNBC-TV18 that company's Dadra unit has received 11 observations from the US health regulator after an audit.